A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₩272,672.89, with a 24-hour trading volume of ₩503.93B. The asset's market cap is ₩422.77T, after moving -1.44% in the last day.
Tokenized AstraZeneca PLC is trading at ₩152,477.91, with a tokenized market cap of ₩86.32B and a 24-hour trading volume of ₩1.11B. The tokenized asset has moved 11.01% in the past 24 hours.